Dental Care Clinics in Riverbank, CA Accepting Medicare
5 Dental Care Clinics found. Showing 1 - 5
 Brent Bell Dds Dentist Medicare: Not Enrolled in Medicare Practice Location: 2754 Topeka St, Riverbank, CA 95367 Phone: 209-869-4505 |
Momani Dds Inc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 3309 Sierra St, Riverbank, CA 95367 Phone: 209-872-3399 Fax: 209-502-6969 |
Riverbank Smiles Dental Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 2119 Patterson Rd, Suite 9, Riverbank, CA 95367 Phone: 209-315-5299 |
Valley Dentures Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 2119 Patterson Rd Ste 9, Riverbank, CA 95367 Phone: 650-966-4844 |
Riverbank Modern Dentistry Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 2603 Patterson Rd Ste 5, Riverbank, CA 95367 Phone: 209-315-6300 Fax: 209-315-6363 |
News Archive
Researchers discover cause for the lack of immune defense against tumors
One of the reasons why cancer develops is because regulatory cells inhibit the body's immune defense. Researchers under the helm of the Technical University of Munich have discovered a mechanism for identifying regulatory cells in tumor tissue that suppress an immune response.
A.S.P.E.N. to hold Clinical Nutrition Week 2015 in Long Beach, CA
On Saturday, February 14, 2015, the American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) kicks-off Clinical Nutrition Week 2015 (CNW) in Long Beach, CA, at the Long Beach Convention & Entertainment Center.
New study examines the effectiveness of shielding policy for people vulnerable to COVID-19
Shielding vulnerable people has been central to the response to COVID-19, but how well does it work? A Swansea University research project has received funding to examine the evidence, to see what lessons can be learned for the future.
Agensys commences AGS-16M8F ADC Phase I clinical trial for renal cancer
Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a Phase I clinical trial of AGS-16M8F an antibody-drug conjugate (ADC) that is being developed for the treatment of metastatic renal cancer. An ADC uses the specific binding properties of an antibody to target a toxin in tumor cells, resulting in selective tumor cell killing.
RBFOX2 dysregulation may cause heart damage in diabetic patients
Cardiac complications are the number one cause of death among diabetics. Now a team of scientists has uncovered a molecular mechanism involved in a common form of heart damage found in people with diabetes.
› Verified 5 days ago